Table 4 Survival rates (Kaplan-meier estimates)
From: Effects of immunosuppressive therapy on renal prognosis in primary membranous nephropathy
|  | 12-Month | 36-Month | 60-Month | p value* |
|---|---|---|---|---|
Overall (N = 457) | 67.2% (62.7%, 71.9%) | 59.1% (54.1%, 64.5%) | 54.3% (49.0%, 60.2%) |  |
Group | Â | Â | Â | 0.04 |
Conservative group (N = 225) | 61.2% (54.7%, 68.5%) | 53.0% (46.0%, 61.1%) | 46.1% (38.7%, 54.9%) |  |
Immunosuppressive group (N = 232) | 72.9% (67.0%, 79.2%) | 65.0% (58.4%, 72.5%) | 62.7% (55.7%, 70.7%) |  |